ArticleBMC pregnancy and childbirth2026
Conservative management of placenta accreta spectrum disorders: a retrospective cohort study.
Article in BMC pregnancy and childbirth, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundPlacenta Accreta Spectrum Disorders (PASD) are rare but life-threatening obstetric conditions characterized by abnormal placental adherence into or beyond the myometrium, resultant from previous uterine scarring, often rendering placental separation either impossible or associated with a significant risk of massive hemorrhage. As a result, caesarean hysterectomy is commonly performed following delivery, to manage associated complications. With the rising incidence of PASD paralleling the global increase in cesarean deliveries, there is a growing need to investigate and highlight fertility-preserving surgical alternatives. This study aimed to assess the rate of uterine preservation and maternal and fetal outcomes of conservatively managed placenta accreta spectrum disorders (PASD).
methodsThis retrospective cohort study was performed for conservatively managed patients with PASD at our center between January 2011 and February 2022. Cases were retrieved through operative bookings and codified delivery statistics from the birthing center. Necessary data was then collected through individual chart review.
resultsEleven patients underwent conservative management of PASD, of whom eight were delivered by elective caesarean, two by emergency cesarean, and one was an out-born post-partum transfer. A diagnosis of PASD was suspected antenatally in seven of the patients. Seven patients (63.6%) underwent expectant management, with the placenta left in situ, whereas the other four (36.4%) had extirpative or resective management. A total of 8 patients underwent embolization by interventional radiology immediately following their cesarean, and repeat embolization was performed in two patients. Of the 7 patients managed expectantly, three patients had spontaneous resolution of their residual placenta, three patients underwent interval hysterectomy within a range of 24 to 116 days, while the remaining patient required a curettage. The mean time to resolution of patients who underwent expectant management was 83 days.
conclusionsIn this study, 72.7% of conservatively managed cases of PASD avoided hysterectomy following caesarean delivery. While not without risks, conservative management of PASD can be offered to patients wishing to preserve fertility after individualized counselling.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.